Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
SOLX Gold Shunt for Refractory Glaucoma
- Conditions
- GlaucomaGlaucoma, Open Angle
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- SOLX, Inc.
- Target Recruit Count
- 116
- Registration Number
- NCT01282346
- Locations
- πΊπΈ
University of Alabama, Birmingham, Alabama, United States
πΊπΈVold Vision, PLLC, Springdale, Arkansas, United States
πΊπΈUniversity of California, Irvine, Irvine, California, United States
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
- Conditions
- GlaucomaGlaucoma, Open Angle
- First Posted Date
- 2006-09-29
- Last Posted Date
- 2015-09-18
- Lead Sponsor
- SOLX, Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT00382395
- Locations
- πΊπΈ
North Bay Eye Associates, Petaluma, California, United States
πΊπΈGlaucoma Consultants of Colorado, Littleton, Colorado, United States
πΊπΈInternational Eye Care, Tampa, Florida, United States
SOLX Titanium Sapphire Laser for Trabeculoplasty
- Conditions
- GlaucomaGlaucoma, Open Angle
- First Posted Date
- 2005-09-05
- Last Posted Date
- 2010-01-29
- Lead Sponsor
- SOLX, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT00145535
- Locations
- πΊπΈ
North Bay Eye Associates, Petaluma, California, United States
πΊπΈInternational Eye Care, Tampa, Florida, United States
πΊπΈGlaucoma Associates of New York, New York, New York, United States